The INEOS Oxbridge Doctoral Initiative on Antimicrobial Resistance was a fully funded DPhil programme that allowed selected candidates to study at both Universities of Oxford and Cambridge.
This programme is now over. We are now collaborating with the BBSRC DTP on a new joint programme for start in 2025. We will provide more information on the new programme and application process by the end of the year. Please keep an eye on this webpage and our social media channels for updates.
At the heart of the initiative is an ambition to nurture a diverse cohort of outstanding young scientists who will become equipped to deal with the global challenges posed by the rapidly emerging threat from antimicrobial resistance.
The programme offered:
- Immersion in both Universities
Although registered in either Oxford or Cambridge as their home base, all students will have ample opportunity to spend periods of time as a visitor in the second University, taking part in ongoing collaborations - Collaboration
Each project is distinct and unique for that student, but there will be the opportunity to collaborate with other students and projects within the initiative, with the additional possibility of input from industry. - Funding
Our studentships are fully funded for three and a half years, through the generous support of the Ineos Oxford Institute. This funding covers UK (and international*) University of Cambridge and University of Oxford fees in addition to living costs (stipend), which will be equivalent to the standard Wellcome stipend rate. - Future prospects
By the time you graduate, you will have acquired skills that are in high demand worldwide. This includes expertise in drug discovery, machine learning and analysis of big data. Such skills will support your future ambitions wherever these take you, including academia, pharma and private-sector companies.